Saturday, Apr 20, 2024 | Last Update : 05:01 AM IST

  Science   22 Jan 2021

Science, 22 Jan 2021

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity

One adverse event was reported but was unrelated to the vaccine

22 Jan 2021 4:13 PM

ADVERTISEMENT
ADVERTISEMENT